acute sinusitis
Jump to navigation
Jump to search
Introduction
Defined as inflammation of one or more of the paranasal sinuses, but generally refers to sinus infection. The maxillary sinuses are most frequently involved, either alone with involvement of the ethmoid &/or frontal sinuses. Sphenoid sinusitis is rare & is considered a medical emergency.
Etiology
- bacterial infection
- Streptococcus pneumonia (35%)
- Haemophilus influenzae (35%)
- beta lactamase producing strains resistant to amoxicillin are uncommon in acute sinusitis
- Streptococcus pyogenes & alpha-hemolytic Streptococci (10%)
- Staphylococcus aureus (6%)
- Moraxella catarrhalis (5%)
- beta lactamase producing strains resistant to amoxicillin are uncommon in acute sinusitis
- Eikenella corrodens
- Chlamydia pneumoniae
- Mycoplasma pneumoniae
- anaerobes with polymicrobial infection (50%) in chronicsinusitis
- viruses (9%) {majority of cases[8]}
- dental abscess
- 5-10% of sinusitis
- contiguous spread of bacteria
- hospitalized patients &/or nasopharyngeal intubation
- gram negative bacilli (47%)
- Staphylococcus (35%)
- yeasts (18%) - more common in granulocytopenic patients
Predisposing factors:
- viral upper respiratory tract infection (URI)
- most bacterial sinusitis occurs after an acute viral infection of the nasal mucosa
- sinusitis occurs in 0.5% of patients with URI[6]
- allergic rhinitis
- abuse of topical decongestants
- deviated nasal septum
- nasopharyngeal intubation (i.e. NG tube)
- nasal polyps
- tumors
- bronchiectasis
- immunodeficiency
- strong association with asthma
Pathology
- obstruction of sinus drainage into the nasal cavity
- decreased ciliary action
- increased mucus production
- diminished oxygenation of sinus cavity
- proliferation of anaerobic & facultatively anaerobic bacteria
- impairment of neutrophil function
- decreased immunoglobulin production
- sinusitis is an important trigger for asthma
Clinical manifestations
- major criteria*
- mucopurulent or purulent nasal discharge
- purulent pharyngeal drainage
- minor criteria*
- periorbital edema
- headache
- facial pain/tenderness, may be unilateral
- facial tenderness most useful in frontal sinusitis
- pain exacerbated by bending over or with head movement
- maxillary toothache (pain in upper teeth)
- earache
- sore throat
- hallitosis
- increased wheeze
- fever
- other
- generally patient does not appear very ill
- afebrile or low-grade fever
- nasal congestion, cough
- poor response to over-the-counter nasal decongestants & antihistamines
- abnormal transillumination
- neither sensitive nor specific
- generally requires complete opacification
- ethmoidal sinusitis
- relieved by maintaining head upright
- exacerbated by lying supine
- maxillary sinusitis
- relieved by lying supine
- exacerbated by the head in an upright position
- sphenoidal sinusitis
- symptoms of upper respiratory tract infection uncommon[14]
- 2 or 3 of: upper respiratory tract infection > 7 days, facial pain, purulent discharge yields > 50% likelihood of sinusitis
- red flags
- patient appears acutely ill
- fever
- periorbital edema
- neurologic signs[6]
* 2 major criteria or 1 major & 2 minor criteria indicates probable sinusitis
Diagnostic criteria
- persistent symptoms lasting at least 10 days, without improvement
- severe symptoms or high fever & purulent nasal discharge or facial pain for 3-4 days at onset of illness[6]
- worsening symptoms after an initial respiratory infection, lasting 5-6 days, has started to improve[17][21]
Laboratory
- generally sinusitis is a clinical diagnosis
- sinus aspiration & culture is gold standard
- useful for guiding antibiotic coverage in refractory sinusitis
- culture of nasal secretions is useless
Diagnostic procedures
- endoscopy
- sinus aspiration & culture
- useful for draining sinus
Radiology
- imaging not routinely recommended[6]
- treat empirically[27]
- immunocompromised patients may be exception[6]
- conventional radiographs
- useful for confirming acute maxillary sinusitis
- poor visualization of ethmoid sinuses
- computed tomography (coronal sinus CT)
- visualization of ethmoid sinuses
- 90-100% sensitivity, 60% specificity
- method of choice
- magnetic resonance imaging
Complications
- subdural & cerebral abscess
- orbital cellulitis via spread from ethmoid sinusitis
- osteomyelitis
- meningitis
- cavernous sinus thrombosis
Differential diagnosis
- inflammatory
- allergic rhinitis (common)
- viral rhinitis (common)
- nasal polyps
- Wegener's granulomatosis
- sarcoidosis
- non-inflammatory
- idiopathic vasomotor rhinitis (common)
- drug-induced vasomotor rhinitis
- rhinitis medicamentosa (common)
- hormonal
- mechanical
- deviated nasal septum (common)
- nasal polyps
- tumor
- foreign body
- other disorders with sinus involvement
- migraine[15]
Management
- non-pharmaceutical measures:[11]
- pharmaceutical agents
- symptomatic relief with topical decongestants, intranasal corticosteroids & antihistamines[6]
- decongestants
- no evidence of benefit[2][3]; appropriate[6]
- oxymetazoline (Afrin) nasal spray BID for 3-5 days
- interferes with healing of maxillary sinusitis by decreasing nasal mucosal blood flow[2]
- phenylephrine (Neo-Synephrine)
- 2-3 sprays every 4 hours for 5 days
- preferred agent
- pseudoephedrine (Sudafed) 120 mg PO BID
- nasal corticosteroids[22]
- limited role in acute sinusitis[12]
- useful for treatment of allergic rhinitis
- may be useful for persistent rhinosinusitis[10]
- no benefit of systemic corticosteroids[19]
- antihistamines
- thicken secretions, non-sedating antihistamines are less likely to thicken secretions
- not indicated in treatment of acute sinusitis
- ref[6] advocates use of antihistamines
- useful for treatment of allergic rhinitis
- mucolytic agents - guaifenesin 30 mL QID
- inhalation of steam
- nasal saline
- antibiotics
- indications: see diagnostic criteria
- amoxicillin or amoxicillin clavulanate (Augmentin) for 5-10 days for acute bacterial sinusitis[17][22] (1st line)
- amoxicillin less effective amoxicillin clavulanate (Augmentin) due to resistance of Haemophilus influenzae & Moraxella[6][27]
- penicillin or amoxicillin as effective & associated with fewer adverse events than amoxicillin clavulanate or cephalosporins in children[24]
- Bactrim or macrolides not recommended because of high rates of antimicrobial resistance[17]
- if Haemophilus or Moraxella suspected
- Augmentin
- 2nd generation cephalosporins
- azithromycin (Zithromax)
- fluoroquinolone
- levofloxacin, moxifloxacin or gatifloxacin
- avoid older fluoroquinolones (ciprofloxacin, ofloxacin); NOT effective against pneumococcus
- if prior antibiotic use, ceftriaxone or fluoroquinolone[8]
- duration of therapy: 5-7 days[25]
- levofloxacin 750 mg QD for 5 days (Leva-pak)[9]
- older guidelines of 10-14 days commonly followed[25]
- antibiotics not useful[12]; useful in children[14]
- amoxicillin 500 mg PO TID no better than placebo[16]
- number needed to treat (NNT) with antibiotics for faster resolution = 15-18; number needed to harm = 8 for medication adverse effects (diarrhea, vomiting, skin rash)[23]
- antifungal agents may be useful in cases of allergic fungal sinusitis with polyposis[26]
- patient education
- most patient feel subjective improvement after 5-6 days of effective therapy
- prolonged use of topical decongestants may cause rebound vasodilation with worsening of symptoms
- avoidance of allergens in patients with underlying allergies
- indications for referral to otolaryngologist
- patients not improving with therapy
- recurrent sinusitis
- acute invasive fungal sinusitis requires hospitalization & surgery
More general terms
More specific terms
- acute ethmoidal sinusitis
- acute frontal sinusitis
- acute maxillary sinusitis
- acute rhinosinusitis
- acute sphenoidal sinusitis
Additional terms
References
- ↑ Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 90-92
- ↑ 2.0 2.1 2.2 Faga LJ, American Family Physician 58:1795-1802, 1998
- ↑ 3.0 3.1 Zeiger RS, J Allergy Clin Immunol 90:478-495, 1992
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 24-25, 795-96
- ↑ The Sanford Guide to Antimicrobial Therapy, 29th ed., Gilbert, DN et al (editors), Antimicrobial Therapy, Inc., Hyde Park VT, 1999
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 6.9 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015
- ↑ Prescriber's Letter, 7(9): 49-50 (Sept), 2000
- ↑ 8.0 8.1 8.2 Selected Treatment Issues in the Updated Guidelines for Community-Acquired Pneumonia in Immunocompetent Adults and Bacterial Sinusitis Prescriber's Letter 11(2):12 2004 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=200209&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 9.0 9.1 Prescriber's Letter 12(9): 2005 High-dose, Short-course Levaquin (Leva-pak) for Acute Bacterial Rhinosinusitis Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=2111005&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 10.0 10.1 Meltzer EO et al, Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005 Dec; 116:1289 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16337461
- ↑ 11.0 11.1 Acute Sinusitis, JAMA patient page JAMA Dec 5 1007, 298:2576
- ↑ 12.0 12.1 12.2 Williamson IG et al, Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: A randomized controlled trial. JAMA 2007, 298:2487 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18056902
Lindbaek M Acute sinusitis - To treat of not to treat? JAMA 2007, 298:2543 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18056909 - ↑ Rosenfeld RM et al, Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007 Sep;137(3 Suppl):S1-31 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17761281 guideline updated 2015 see ref [22]
- ↑ 14.0 14.1 14.2 Wald ER et al. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics 2009 Jul; 124:9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19564277
- ↑ 15.0 15.1 15.2 Ferguson BJ et al. Prospective observational study of chronic rhinosinusitis: Environmental triggers and antibiotic implications. Clin Infect Dis 2012 Jan 1; 54:62. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22114094
- ↑ 16.0 16.1 Garbutt JM et al Amoxicillin for Acute Rhinosinusitis: A Randomized Controlled Trial JAMA. 2012;307(7):685-692 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22337680 <Internet> http://jama.ama-assn.org/content/307/7/685.short
- ↑ 17.0 17.1 17.2 17.3 Chow AW et al IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults Clin Infect Dis. March 20, 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22438350 <Internet> http://cid.oxfordjournals.org/content/early/2012/03/20/cid.cir1043.full
- ↑ Prescriber's Letter 19(4): 2012 COMMENTARY: Treatment of Acute Rhinosinusitis in Adults PATIENT EDUCATION HANDOUT: Viral Illness Rx Pad PATIENT EDUCATION HANDOUT SPANISH VERSION: Viral Illness Rx Pad Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=280422&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 19.0 19.1 Venekamp RP et al Systemic corticosteroid monotherapy for clinically diagnosed acute rhinosinusitis: a randomised control trial. CMAJ August 7, 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22872770 <Internet> http://www.cmaj.ca/content/early/2012/08/07/cmaj.120430.full.pdf+html
- ↑ Wald ER et al Clinical Practice Guideline for the Diagnosis and Management of Acute Bacterial Sinusitis in Children Aged 1-18 years. Pediatrics. June 24, 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23796742 <Internet> http://pediatrics.aappublications.org/content/early/2013/06/19/peds.2013-1071.full.pdf+html
- ↑ 21.0 21.1 Hersh AL et al Principles of Judicious Antibiotic Prescribing for Bacterial Upper Respiratory Tract Infections in Pediatrics. Pediatrics. Nov 8, 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24249823 <Internet> http://pediatrics.aappublications.org/content/early/2013/11/12/peds.2013-3260.full.pdf+html
- ↑ 22.0 22.1 22.2 Rosenfeld RM et al Clinical Practice Guideline (Update). Adult Sinusitis Executive Summary. Otolaryngol Head Neck Surg April 2015 vol. 152 no. 4 598-609 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25833927 <Internet> http://oto.sagepub.com/content/152/4/598.full
- ↑ 23.0 23.1 The NNT: Antibiotics for Clinically Diagnosed Acute Sinusitis in Adults http://www.thennt.com/nnt/antibiotics-for-clinically-diagnosed-acute-sinusitis/
Lemiengre MB, van Driel ML, Merenstein D, Young J, De Sutter AI. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev. 2012 Oct 17;10:CD006089 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23076918
The NNT: Antibiotics for Radiologically-Diagnosed Acute Maxillary Sinusitis. http://www.thennt.com/nnt/antibiotics-for-radiologically-diagnosed-sinusitis/
Ahovuo-Saloranta A, Borisenko OV, Kovanen N Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000243. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18425861 - ↑ 24.0 24.1 Gerber JS, Ross RK, Bryan M et al Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections. JAMA. 2017;318(23):2325-2336 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29260224 https://jamanetwork.com/journals/jama/article-abstract/2666503
- ↑ 25.0 25.1 25.2 King LM, Sanchez GV, Bartoces M et al Antibiotic Therapy Duration in US Adults With Sinusitis. JAMA Intern Med. Published online March 26, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29582085 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2674867
- ↑ 26.0 26.1 Archer SM, Meyers AD Nonsurgical Treatment of Nasal Polyps.. Medscape. April 1, 2021 https://emedicine.medscape.com/article/861353-treatment
- ↑ 27.0 27.1 27.2 NEJM Knowledge+ Allergy/Immunology